In the early 2010s, Jose Florez and his collaborators knew that a disproportionate number of people from Latin America suffered from type 2 diabetes, but they didn’t know why. The researchers pored through genetic databases looking for markers unique to these patients, but most information in these databases is from people of European ancestry, which limited the ability of researchers to find meaningful clues.
